Related Experiment Video

Updated: Jul 5, 2025

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.6K

Correction: Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates

Tricia H Burdo1, Chen Chen2, Rafal Kaminski2

  • 1Department of Microbiology, Immunology, and Inflammation, Center for NeuroVirology and Gene Editing, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 19140, USA. burdot@temple.edu.

Gene Therapy
|January 11, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Gene Editing of Primary Rhesus Macaque B Cells
09:53

Gene Editing of Primary Rhesus Macaque B Cells

Published on: February 10, 2023

2.5K
Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
11:28

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

17.6K

Related Experiment Videos

Last Updated: Jul 5, 2025

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.6K
Gene Editing of Primary Rhesus Macaque B Cells
09:53

Gene Editing of Primary Rhesus Macaque B Cells

Published on: February 10, 2023

2.5K
Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
11:28

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

17.6K

Related Concept Videos

CRISPR01:59

CRISPR

51.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.1K

Articles linked to this work by shared authors, journal, and citation graph.

Triple-Target CRISPR Strategy to Block HIV Entry and Replication in Permissive Cells.

Human gene therapy·2026

Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates.

Gene therapy·2023

CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice.

Proceedings of the National Academy of Sciences of the United States of America·2023

CRISPR based editing of SIV proviral DNA in ART treated non-human primates.

Nature communications·2020

Age-related neurodegenerative diseases.

Journal of cellular physiology·2019

Evidence for the impact of BAG3 on electrophysiological activity of primary culture of neonatal cardiomyocytes.

Journal of cellular physiology·2019

Patient, consumer and societal values, perceptions and preferences on high-cost gene therapies.

Gene therapy·2026

Intratumor delivery of a novel plasmid combination induces high levels of metastatic melanoma regression.

Gene therapy·2026

Culture media alter retinal organoid physiology promoting AAV transduction and retinal ganglion cell survival.

Gene therapy·2026

Optogenetic vision restoration: translational barriers and emerging therapeutic strategies.

Gene therapy·2026

Mapping the global trends and hotspots of research on gene therapy and hair cell regeneration for hearing loss: a comprehensive data-mining-based study.

Gene therapy·2026

An engineered helper plasmid generates differential E4orf6 and L4-22/33K gene expression increasing AAV vector production.

Gene therapy·2026

Therapeutic hybrid intelligence with neural and knowledge-based expert reasoning for SRS: an AI model for breast cancer brain metastases.

Frontiers in oncology·2026

Re-Examining the Applicability of the Linear No-Threshold (LNT) Theory in Radiation Protection for Very Low Doses: Does a Threshold Exist? The Carcinogenic Effect of Radiation and the Possibility of a Dose Threshold.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Comparative Physicochemical Characterization and Biological Effects of Magnetite- and Maghemite-Based Magnetic Colloidal Suspensions in A704 Renal Cancer Cells.

Pharmaceuticals (Basel, Switzerland)·2026

Drug Repurposing of Verapamil for Radiation-Induced Enteropathy: Regulation of 5-LOX, Nrf2, and Intestinal Barrier Function.

Pharmaceuticals (Basel, Switzerland)·2026

Reprogramming Photodynamic Therapy with BODIPY Photosensitizers: From Local Phototoxicity Toward Precision Photodynamic Oncology.

Molecules (Basel, Switzerland)·2026

Radiotherapy Modality and Primary Tumor Type as Determinants of Outcomes in Brain Metastases: A Retrospective Study of 734 Patients.

Medicina (Kaunas, Lithuania)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us